1. Advocat, C. D., Mayville, E. A., & Matson, J. L. (2000). Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with intellectual disability. Research in Intellectual Disabilities, 21, 75–84.
2. Aman, M. G., & Singh, N. N. (1988). Psychopharmacology of intellectual disabilities. New York: Springer-Verlag.
3. Aman, M. G., Sarphare, G., & Burrow, W. H. (1995). Psychotropic drugs in group homes: Prevalence and relation to demographic/psychiatric variables. American Journal of Intellectual Disability, 99, 500–509.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (Text Revision). Washington: Author.
5. Bates, W. J., Smeltzer, D. J., & Arnoczky, S. M. (1986). Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons. American Journal of Mental Deficiency, 90, 363–370.